Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment?

Mohamed S. Dabour, Adnan Shaaban, Daniel A. Duprez, Beshay N. Zordoky, Anne H. Blaes

Open source

DOI
10.1007/s10549-026-08007-2
Published
2026-06
Container
Breast Cancer Research and Treatment
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10549-026-08007-2,
  title = {Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment?},
  author = {Mohamed S. Dabour and Adnan Shaaban and Daniel A. Duprez and Beshay N. Zordoky and Anne H. Blaes},
  year = {2026},
  journal = {Breast Cancer Research and Treatment},
  doi = {10.1007/s10549-026-08007-2},
  url = {https://doi.org/10.1007/s10549-026-08007-2}
}

RIS

TY  - JOUR
TI  - Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment?
AU  - Mohamed S. Dabour
AU  - Adnan Shaaban
AU  - Daniel A. Duprez
AU  - Beshay N. Zordoky
AU  - Anne H. Blaes
PY  - 2026
JO  - Breast Cancer Research and Treatment
DO  - 10.1007/s10549-026-08007-2
UR  - https://doi.org/10.1007/s10549-026-08007-2
ER  - 

APA

Dabour, M. S., Shaaban, A., Duprez, D. A., Zordoky, B. N., & Blaes, A. H. (2026). Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment?. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-08007-2

Source records